Where the Money Goes

You are here

Home » Cure4Cam Childhood Cancer Foundation

Cure4Cam Childhood Cancer Foundation

The Cure4Cam Childhood Cancer Foundation supports the development of new, more effective and safer therapies to treat childhood cancer. Today’s standard treatments can be highly toxic, creating intolerable side effects and causing lasting health issues. Cure4Cam was founded in honor of Cameron Evans, a top runner for his middle school cross country team with a passion for technology, who, only days after competing in a middle school championship cross country race, was diagnosed with leukemia. After a tough fight, Cameron passed away at age 14. The Cure4Cam Foundation raises money to fund new and innovative cancer research to develop therapies that target individual cancer cells.

Visit Cure4Cam Childhood Cancer Foundation for more information

Co-Funded Projects

Project Title Institutions Co-Funder(s)
Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells Stanford University School of Medicine Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Kate's Cause
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies Dana-Farber Cancer Institute Cure4Cam Childhood Cancer Foundation
ECM-targeted CAR T-cell therapy for high-grade glioma St. Jude Children’s Research Hospital Cure4Cam Childhood Cancer Foundation
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs University of Alberta Cure4Cam Childhood Cancer Foundation
Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients Vanderbilt University Medical Center Cure4Cam Childhood Cancer Foundation
Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children Fred Hutchinson Cancer Research Center Cure4Cam Childhood Cancer Foundation
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity University of Texas M.D. Anderson Cancer Center Cure4Cam Childhood Cancer Foundation
Targeting Oncogenic RAS in Pediatric Leukemia Dana-Farber Cancer Institute Cure4Cam Childhood Cancer Foundation
Physical Properties of Drug-Resistant Leukemia Cells Children’s Hospital Los Angeles Cure4Cam Childhood Cancer Foundation
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia New York University School of Medicine Cure4Cam Childhood Cancer Foundation

Pages

Featured Hero

Ellie Jade Timmer

Ellie was a sweet and sassy little girl who brought joy to everyone around her. Shortly after Ellie turned 2 years old, she was diagnosed with a rare leukemia called JMML. Sadly, Ellie passed away, but never lost her smile throughout her fight.
Read more »